To this end, Sharma et al., in the first set of experiments, defined the guide RNA for optimal targeting of HBG1 and HBG2 promoters; then, using gRNA-68 selected for clinical studies, edited CD34+ cells isolated from SCD patients [95]. The gene discussed is HBG2; the disease is Schnyder corneal dystrophy.